Vimarsana
Biggest News Aggregation in the World

Page 7 - Johan Dalsgaard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan Dalsgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Dalsgaard Today - Breaking & Trending Today

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients - Vimarsana News

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2...

Vicore Pharma Holding AB: Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients - Vimarsana News

Vicore Pharma Holding AB: Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

GOTHENBURG, Sweden, Feb. 10, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients - Vimarsana News

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2...

Interim report July - September 2021 - Vimarsana News

Interim report July - September 2021

/PRNewswire/ -- Important events during the third quarter In August, Vicore announced a strenghtened management team with three senior recruitments; Jessica...

Vicore Pharma Holding AB: Interim report July - Vimarsana News

Vicore Pharma Holding AB: Interim report July

- Vicore Pharma Holding AB (publ) publishes the interim report for the third quarter 2021 GOTHENBURG, Sweden, Nov. 4, 2021 /PRNewswire/ -- Important events during the third quarter In